pharma

Drugmaker to pay $1.4B in largest US opioid treatment settlement

Reckitt Benckiser Group has agreed to pay up to $1.4 billion to resolve a long-running United States federal investigation into the company's sales and marketing of Suboxone, a prescription drug used to treat people addicted to heroin, painkillers and other opioids.

Former pharma execs hit with drug trafficking charges

Two former executives of a pharmaceutical distributor company are facing criminal drug trafficking charges on accusations of illegally distributing opioids and conspiring to defraud the US Drug Enforcement Administration, the first time distributors have been criminally charged with these crimes.